PRA Health Sciences, Inc.
PRAH
PRAH was delisted on the 30th of June, 2021.
300 hedge funds and large institutions have $6.04B invested in PRA Health Sciences, Inc. in 2018 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 92 increasing their positions, 109 reducing their positions, and 34 closing their positions.
71% more first-time investments, than exits
New positions opened: 58 | Existing positions closed: 34
14% more capital invested
Capital invested by funds: $5.29B → $6.04B (+$746M)
8% more funds holding
Funds holding: 278 → 300 (+22)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
16% less repeat investments, than reductions
Existing positions increased: 92 | Existing positions reduced: 109
60% less call options, than puts
Call options by funds: $3.54M | Put options by funds: $8.91M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$99.8M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$90.6M |
| 3 |
Bank of New York Mellon
New York
|
+$58M |
| 4 |
Jennison Associates
New York
|
+$52.7M |
| 5 |
State Street
Boston,
Massachusetts
|
+$25.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$44.5M |
| 2 |
MWNA
Marshall Wace North America
New York
|
-$26.5M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$26.2M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$22.7M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$20.9M |
PRAH Hedge Fund Activity: Q2 2018 in Review
300 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in PRA Health Sciences, Inc. (PRAH) for Q2 2018, worth a combined $6.04B — up 14% from $5.29B a quarter earlier.
Buyers outnumbered sellers: 58 funds opened new PRAH positions and 34 closed out — a net gain of 24 holders — while 92 added to existing stakes and 109 trimmed.
The largest buyer was BlackRock, adding an estimated $99.8M. The largest seller was Capital Research Global Investors, cutting an estimated $44.5M.
- 300 institutional investors held PRA Health Sciences, Inc. (PRAH) as of Q2 2018, up from 278 in Q1 2018.
- Funds reported $6.04B of PRA Health Sciences, Inc. stock for Q2 2018, up 14% quarter-over-quarter.
- 58 funds opened new PRA Health Sciences, Inc. positions in Q2 2018 and 34 closed out, a net change of +24 holders.
- The largest PRA Health Sciences, Inc. buyer in Q2 2018 was BlackRock, an estimated $99.8M added.
- The largest PRA Health Sciences, Inc. seller in Q2 2018 was Capital Research Global Investors, an estimated $44.5M sold.
Based on aggregated 13F filings for Q2 2018.